New hope for Tough-to-Treat blood cancer: first human trial begins
Disease control
Recruiting now
This is the first study in people testing a new drug called ISB 2001 for multiple myeloma that has returned or stopped responding to all standard treatments. Researchers will give increasing doses to about 200 participants to find a safe amount and see if it helps control the can…
Phase: PHASE1 • Sponsor: Ichnos Sciences SA • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC